Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer
Feng Ming Kong, Chen Hu, Daniel A. Pryma, Fenghai Duan, Martha Matuszak, Ying Xiao, Randall Ten Haken, Marilyn J. Siegel, Lucy Hanna, Walter Curran, Mark Dunphy, Daphna Gelblum, Morand Piert, Shruti Jolly, Clifford G. Robinson, Andrew Quon, Billy W. Loo, Shyam Srinivas, Gregory M. Videtic, Sergio L. FariaCatherine Ferguson, Neal E. Dunlap, Vijayananda Kundapur, Rebecca Paulus, Barry A. Siegel, Jeffrey D. Bradley, Mitchell Machtay
Dive into the research topics of 'Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer'. Together they form a unique fingerprint.